title: Immunological characteristics of lymphoblasts and lymphocytes in acute lymphoblastic leukaemia in children.
abstract: By analysing the electrophoretic mobility (EM) of lymphocytes and by comparing their surface charge it is possible to distinguish rapid-moving lymphocytes (T) and slow-moving lymphocytes (B). The authors studied the EM of blood lymphocytes in children suffering from acute lymphoblastic leukaemia, before they underwent treatment. At the same time they carried out a study of classical immunological markers (E rosettes, membrane immunoglobulins, and blastic-transformation ability). The authors were able to distinguish three types of lymphocytes according to their EM i.e., rapid, slow or intermediate. This heterogeneousness could be explained by the fact that the origin of leukaemic proliferation may vary according to different stages in the maturation of the lymphoid cells. It would seem premature to establish any correlation between the initial clinical signs of the disease and its evolution.
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004586:Electrophoresis; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000276:immunology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D011947:Receptors, Antigen, B-Cell; D012397:Rosette Formation
chemical_list: D011947:Receptors, Antigen, B-Cell
references.citation: Clin Exp Immunol. 1970 May;6(5):681-8
references.pmid: 5477925
references.citation: Biomedicine. 1975 Apr 30;23(4):121-5
references.pmid: 1063045
references.citation: J Immunol. 1974 Feb;112(2):836-43
references.pmid: 4591979
references.citation: Nat New Biol. 1971 Dec 22;234(51):251-2
references.pmid: 4942988
references.citation: Biomedicine. 1975 Sep 10;23(7):283-90
references.pmid: 1066167
references.citation: Clin Exp Immunol. 1973 Sep;15(1):131-43
references.pmid: 4520119
references.citation: Pediatrics. 1975 Nov;56(5):788-92
references.pmid: 1081671
references.citation: Semin Oncol. 1976 Sep;3(3):271-82
references.pmid: 1068529
references.citation: Cancer Res. 1974 Mar;34(3):521-5
references.pmid: 4590920
references.citation: J Exp Med. 1972 Aug 1;136(2):207-15
references.pmid: 4114496
references.citation: N Engl J Med. 1976 Jan 29;294(5):275-6
references.pmid: 1081642
references.citation: Ann Immunol (Paris). 1974 Aug-Sep;125 C(5):691-6
references.pmid: 4617552
references.citation: Ann N Y Acad Sci. 1975 Feb 28;249:484-91
references.pmid: 1055575
references.citation: N Engl J Med. 1975 Apr 10;292(15):775-80
references.pmid: 1054106
references.citation: Science. 1973 Dec 28;182(4119):1355-6
references.pmid: 4586464
references.citation: Nature. 1974 Jan 25;247(5438):213-5
references.pmid: 4589574
references.citation: Clin Exp Immunol. 1973 Dec;15(4):497-506
references.pmid: 4591639
references.citation: Clin Exp Immunol. 1975 Jan;19(1):159-65
references.pmid: 1081923
references.citation: Lancet. 1974 Sep 28;2(7883):753-5
references.pmid: 4143016
references.citation: Clin Immunol Immunopathol. 1975 Sep;4(3):440-8
references.pmid: 127680
references.citation: Clin Exp Immunol. 1973 Feb;13(2):171-81
references.pmid: 4266346
references.citation: J Clin Invest. 1972 Oct;51(10):2537-43
references.pmid: 4115705
references.citation: Cytobios. 1975;12(46):79-88
references.pmid: 1081030
references.citation: Lancet. 1972 Oct 28;2(7783):927
references.pmid: 4116628
references.citation: Semin Oncol. 1976 Sep;3(3):243-51
references.pmid: 185724
references.citation: Biomedicine. 1974 Mar;20(2):109-18
references.pmid: 4605201
references.citation: Br Med J. 1974 Jun 22;2(5920):643-6
references.pmid: 4546214
references.citation: N Engl J Med. 1976 Jan 29;294(5):245-8
references.pmid: 53789
references.citation: J Immunol. 1973 Mar;110(3):884-7
references.pmid: 4540134
references.citation: N Engl J Med. 1975 Apr 17;292(16):828-32
references.pmid: 1078713
references.citation: Biomedicine. 1974 Feb;21(2):86-90
references.pmid: 4604421
references.citation: Blood. 1975 Jun;45(6):871-80
references.pmid: 1079147
references.citation: J Exp Med. 1971 Jun 1;133(6):1188-98
references.pmid: 4102685
references.citation: J Natl Cancer Inst. 1974 Aug;53(2):389-92
references.pmid: 4526419
references.citation: Clin Immunol Immunopathol. 1973 Jul;1(4):499-510
references.pmid: 4617644
references.citation: Proc Natl Acad Sci U S A. 1974 Mar;71(3):863-6
references.pmid: 4274561
references.citation: Biomedicine. 1976 Jul;25(6):218-20
references.pmid: 1085643
references.citation: Clin Exp Immunol. 1974 Aug;17(4):561-9
references.pmid: 4219600
references.citation: N Engl J Med. 1974 Jun 20;290(25):1438
references.pmid: 4597887
references.citation: J Exp Med. 1970 Nov;132(5):1001-18
references.pmid: 4919141
references.citation: Immunology. 1973 Apr;24(4):601-6
references.pmid: 4574795
references.citation: Scand J Immunol. 1972;1(3):269-80
references.pmid: 4541574